Yunze Lu

Yunze Lu is a researcher at China Pharmaceutical University, focusing on epidemiology and data-driven biomedical research. His work centers on the integration of advanced statistical methodologies with biological and clinical insights, aiming to uncover the complex mechanisms underlying human diseases.

Leveraging large-scale population and multi-omics databases—including NHANES, GBD, CHARLS, GWAS consortia datasets, GEO, and TCGA—he conducts systematic investigations into the roles of immune regulation, metal ion homeostasis, and metabolic dysfunction in disease development. His research particularly emphasizes liver diseases, autoimmune disorders, and neurological conditions, exploring their interconnections through multi-dimensional data integration.

His work focuses on identifying key risk factors, characterizing biomarker profiles, and elucidating potential biological pathways, with the ultimate goal of improving disease risk stratification and advancing precision medicine. He is actively involved in scholarly publishing and peer review, currently serving as an Editorial Board Member for Silence.